β¨ Environmental and Health Notices
13 APRIL 2006
NEW ZEALAND GAZETTE, No. 35
Environment
Crown Entities Act 2004
Reappointments/appointments to the Environmental Risk Management Authority
Pursuant to section 28 of the Crown Entities Act 2004, I reappoint
Neil Walter (chair)
George Clark (deputy chair)
to the Environmental Risk Management Authority for two-year terms commencing from 10 April 2006; and I also appoint
Valerie Orchard (member)
to the Environmental Risk Management Authority for a two-year term commencing from 1 May 2006.
Dated at Wellington this 13th day of April 2006.
DAVID BENSON-POPE, Minister for the Environment.
go2283
913
Health
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Dilatrend
Active Ingredient:
Carvedilol 12.5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche SpA, Via Morelli, Segrate, Italy
Product:
Dilatrend
Active Ingredient:
Carvedilol 25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche SpA, Via Morelli, Segrate, Italy
Product:
Dilatrend
Active Ingredient:
Carvedilol 3.125mg
Dosage Form:
Tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche SpA, Via Morelli, Segrate, Italy
Product:
Dilatrend
Active Ingredient:
Carvedilol 6.25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche SpA, Via Morelli, Segrate, Italy
Product:
Invanz
Active Ingredient:
Ertapenem sodium 209.2mg/mL equivalent to 200mg/mL ertapenem free acid
Dosage Form:
Powder for injection
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturer:
Laboratoires Merck Sharp & Dohme - Chibret, Clermont-Ferrand, France
Product:
Tamiflu
Active Ingredient:
Oseltamivir phosphate 98.5mg equivalent to 75mg oseltamivir
Dosage Form:
Capsule
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
F Hoffmann-La Roche AG, Basel, Switzerland
Product:
Tamiflu
Active Ingredient:
Oseltamivir phosphate 39.4mg/g equivalent to oseltamivir 12mg/mL when reconstituted with 52mL of water
Dosage Form:
Powder for oral suspension
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
F Hoffmann-La Roche AG, Basel, Switzerland
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 35
Gazette.govt.nz —
NZ Gazette 2006, No 35
β¨ LLM interpretation of page content
ποΈ Reappointments and Appointments to the Environmental Risk Management Authority
ποΈ Governance & Central Administration13 April 2006
Environmental Risk Management Authority, Appointments, Reappointments, Crown Entities Act 2004
- Neil Walter, Reappointed chair of Environmental Risk Management Authority
- George Clark, Reappointed deputy chair of Environmental Risk Management Authority
- Valerie Orchard, Appointed member of Environmental Risk Management Authority
- DAVID BENSON-POPE, Minister for the Environment
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare13 April 2006
Medicines Act 1981, Changed Medicines, Consent, Distribution, Dilatrend, Invanz, Tamiflu
- Minister of Health